Solutions
Neurosurgeon operating with intraoperative brain imaging
Neurosurgery
Functional brain-network data for complex neurosurgical decisions.
Clinician reviewing brain imaging on a monitor
Neurology
Objective brain function insights for more informed neurological care.
Older couple walking outdoors
Brain Health
Supporting healthier brains through earlier insight.
Clinicians reviewing a brain scan on a monitor
Clinical Research
Empowering the next generation of neuroscience research.
TechnologyResourcesQuantalX NeuroscienceReimbursementAboutContact us
QuantalX Neuroscience
All resources
Peer-reviewed publication
Journal of Clinical Neuroscience
2025

TMS-evoked potentials: Neurophysiological biomarkers for diagnosis and prediction of response to ventriculoperitoneal shunt in normal pressure hydrocephalus

Davidy T, Anis S, Suminski A, Zauberman Y, Fay-Karmon T, Saar A, Zifman N, Fogel H, Abulher E, Lesman-Segev O, Hassin-Baer S

Journal of Clinical Neuroscience journal cover
Key finding

In this initial cohort, a TEP-based Delphi-NPH index separated shunt responders from non-responders with an ROC-AUC of 0.91, higher than the imaging, gait and tap-test measures studied.

Study design
Clinical study, TMS-EEG with automated TEP analysis (Delphi)
Participants
37 patients with possible iNPH and 16 healthy controls

Summary

Selecting patients with normal pressure hydrocephalus (NPH) for a ventriculoperitoneal shunt (VPS) currently relies on clinical presentation, imaging and invasive procedures such as the cerebrospinal fluid tap test. This study assessed whether an evaluation based on TMS-evoked potentials (TEPs) could predict which patients respond to the shunt.

Study design

  • Participants: 37 patients with possible idiopathic NPH (iNPH) and 16 age-matched healthy controls.
  • All participants underwent Delphi (TMS-EEG with automated TEP analysis) with stimulation of the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC).
  • 16 patients underwent VPS. Response after 3 months was assessed with the modified Rankin Scale, the clinical global impression of change (CGIC) for gait, and a repeated 3-meter timed up and go (TUG) test.

Key findings

  • The TEP Delphi-NPH index discriminated VPS responders with an ROC-AUC of 0.91 (p = 0.006).
  • For comparison, imaging measures reached AUCs of 0.58 to 0.83, the TUG test 0.63 and the tap test 0.65.
  • M1 P60 and P180 latencies were earlier in responders than in controls (p = 0.016 and p = 0.009).
  • TEP measures correlated with the CGIC rank and with the change in TUG times.

Authors' conclusions

The authors describe these as initial results suggesting that TEPs may be an alternative to the tap test for predicting response to VPS in suspected iNPH, with less discomfort and risk for patients, pending replication in a larger sample with longer follow-up.

Read the full article

Davidy T, Anis S, Suminski A, Zauberman Y, Fay-Karmon T, Saar A, Zifman N, Fogel H, Abulher E, Lesman-Segev O, Hassin-Baer S. TMS-evoked potentials: Neurophysiological biomarkers for diagnosis and prediction of response to ventriculoperitoneal shunt in normal pressure hydrocephalus. Journal of Clinical Neuroscience. 2025;136:111234. doi:10.1016/j.jocn.2025.111234

Summary prepared by QuantalX from the published abstract. All results are as reported by the authors. The full text is available from the publisher.

Bring brain function data into your practice

Talk to the QuantalX team about Delphi-MD™ in your clinical setting.

Request a demo
On this page
Section
Journal
Journal of Clinical Neuroscience
Year
2025
DOI
10.1016/j.jocn.2025.111234
Licence
Copyright Elsevier. Summary by QuantalX
Read in the journal
QuantalX Neuroscience
Join our newsletter to stay up to date on clinical updates and company news.
By subscribing you agree to our Privacy Policy and provide consent to receive updates from our company.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Solutions
NeurosurgeryNeurologyBrain HealthClinical ResearchPsychiatry
Company
TechnologyPartner ZoneResourcesAbout UsContact
Follow us
Facebook
Instagram
X
LinkedIn
© 2026 Quantalx. All rights reserved.
Privacy PolicyTerms of Service
*All clinical interpretations of Delphi-MD™ assessments must be made by qualified healthcare professionals within the context of a full patient evaluation. The Delphi-MD™ system is intended to elicit, record, and analyze TMS-evoked brain potentials (TEPs) and provide quantitative output parameters compared against a normative reference database limited to ages 50–75. Adverse events during or after evaluation may include headache, nausea, dizziness, fatigue, insomnia, anxiety/agitation, back or neck pain, vomiting, tinnitus, migraine aura, and abnormal sensations. Delphi-MD™ is not intended to be relied upon solely to make or confirm a diagnosis. For more information, refer to the Delphi-MD™ user manual.
Schedule a Demo